![Dennis Hom](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Dennis Hom
Finanzdirektor/CFO bei
PROQR THERAPEUTICS N.V.
Profil
Dennis Hom currently works at ProQR Therapeutics NV, as Chief Financial Officer from 2025.
Mr. Hom also formerly worked at Amgen, Inc., as Executive Director-Corporate Development from 2011 to 2012, Achaogen, Inc., as Vice President-Finance & Corporate Development from 2013 to 2014, and Sagimet Biosciences, Inc., as CFO & Head-Corporate Development from 2017 to 2023.
Mr. Hom received his undergraduate degree from Massachusetts Institute of Technology.
Aktive Positionen von Dennis Hom
| Unternehmen | Position | Beginn |
|---|---|---|
| PROQR THERAPEUTICS N.V. | Finanzdirektor/CFO | 14.04.2025 |
Ehemalige bekannte Positionen von Dennis Hom
| Unternehmen | Position | Ende |
|---|---|---|
| SAGIMET BIOSCIENCES INC. | Finanzdirektor/CFO | 01.08.2023 |
| ACHAOGEN | Finanzdirektor/CFO | 31.03.2014 |
| AMGEN INC. | Corporate Officer/Principal | 01.01.2012 |
Ausbildung von Dennis Hom
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
61
Beziehungen ersten Grades
5
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Private Unternehmen | 5 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
Achaogen, Inc.
 Achaogen, Inc. Pharmaceuticals: MajorHealth Technology Operates as a a biopharmaceutical company, which engages in the research, development, and commercialization of antibacterial treatments for multi-drug resistant (MDR) gram-negative infections | Health Technology |
Massachusetts Institute of Technology
 Massachusetts Institute of Technology Finance/Rental/LeasingFinance Functions as a College/University | Finance |
Sagimet Biosciences, Inc.
 Sagimet Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops novel therapeutics for the treatment of infectious diseases | Health Technology |
ProQR Therapeutics NV
 ProQR Therapeutics NV Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company with interest in the discovery and development of therapeutics for the treatment of genetic disorders | Health Technology |
